OraSure said its rapid COVID-19 tests can now be used in children
Shares of OraSure Technologies Inc.
OSUR,
gained 2.2% in premarket trading on Monday after the company said its COVID-19 rapid tests have now been authorized for children between the ages of 2 and 14 years old. The tests had previously received emergency use authorization from the Food and Drug Administration for use in teens and adults. OraSure’s stock is down 43.0% over the past year, while the broader S&P 500
SPX,
is up 18.7%.
